AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπΌ
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE in Zimbabwe
5 products registered with MCAZ β 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MDICORVAL 200/6 INHALATION | 2025/22.1.4/6862 | ORANGE HEALTH P/L | active | 12 Feb 2030 |
| MDIOCORVAL 100/6 INHALATION | 2025/22.1.4/6861 | ORANGE HEALTH P/L | active | 12 Feb 2030 |
| AVACORT-BF 200/6 INHALATION | 2020/22.1.4/6008 | INNOVATA PHARMACEUTICALS LTD | active | 31 Dec 2027 |
| AVACORT-BF 100/6 INHALATION | 2020/22.1.4/6007 | INNOVATA PHARMACEUTICALS LTD | active | 31 Dec 2027 |
| AVACORT-BF 400/12 INHALATION | 2020/22.1.4/6009 | INNOVATA PHARMACEUTICALS LTD | active | 31 Dec 2027 |
BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE β MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.